Kessler Topaz Meltzer & Check, LLP Files Securities Fraud Class Action Lawsuit Against AbbVie, Inc. Pharmaceutical Investing
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
SHAREHOLDER ALERT: VLTA IBM AUPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AbbVie Inc. Pharmaceutical Investing
LAWSUITS FILED AGAINST TASK, AFRM and ABBV - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GRAB, MYPS and AUPH Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VRT, ABBV and SDIG Pharmaceutical Investing
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland Pharmaceutical Investing
